Novel Drug Delivery System (NDDS) & Clinical Trail Management China2013

Time:November 27-28, 2013

Country&Region:Shanghai, Shanghai, China Mainland

Venue:Sheraton Hongkou Shanghai, China

Organizer:CPhI Conferences & UBM Conferences

  • Share on Facebook
  • Tweet
  • Post to Tumblr
  • Pin it
  • Add to Pocket
  • Submit to Reddit
  • Share on LinkedIn
  • Publish on WordPress
  • Save to Pinboard
  • Send email

 

  • Following the huge success of NDDS China 2011 & 2012, CPhI will host 3rd NDDS China 2013 on 27-28, November in Sheraton Shanghai Hongkou Hotel, China.
     
  • China’s drug delivery system and formulation research level lags behind but with great potential. China National 12th Five Year Plan for Key New Drug R&D Projects has set Novel Drug Delivery System as a key development trend. How to realize product differentiation and enhance the research and commercialization level by making use of the latest drug delivery system and formulation strategy has become an urgent problem for pharmaceutical companies to solve.
     
  • Novel drug delivery is one of the fastest growing pharmaceutical sectors. The three most promising drug delivery systems in China are sustained/controlled release oral DDS, injection DDS and nanopartical DDS. At present there are over 1400 sustained/controlled release drugs worldwide. Sustained/controlled oral release formulation is one of the hotspots with annual increase in new product application and registration.
     
  • In recent years, Novel Drug Delivery Systems (NDDS) has captured the interest all the big and small pharmaceutical re-search organizations, pioneering there research to devise newer strategies for effectively delivering the drugs in the body or improvise the existing technologies to enhance their efficiency in the body.
     
  • The newly improving delivery systems of the originally available drugs are not only beneficial for the patients but also less complicated inters of offering needle free delivery and reduction in the dose of the active ingredients.
     
  • Figures and Facts:

The global Drug Delivery Systems market is projected to reach $196.4 billion by 2014.
There are over 1400 sustained/controlled release drugs worldwide.
Global injectable drug delivery market is expected to be worth $29,981 million by 2015.

 


Who Should Attend?

  • VPs,GMs, CSOs,CTOs
  • Head of R&D/Formulation
  • Head of Drug Deliver System
  • Pharma Analysis
  • Drug/Product Development
  • Business Development
  • Stategy & Marketing
  • Technical Transformation
  • Others



From:

  • Pharma Manufacturers
  • Government & Supervision
  • Research Institutes
  • Drug Deliver Technology Supply
  • CROs & Equipment Provider
  • Ingredient, Excipient & Material Supply
  • Laboratory & Instrument



Why You Should Attend?

  • Deep understands about the drug delivery system development and industrializing insights & gain the latest know how about novel drug delivery and application status-quos
     
  • Meeting with 20+ industrial expert and speakers、50+Pharmaceutical Companies、120+decision-makers interacting
     
  • Finding newer ways of doing NDDs business and finally providing the “value addition” to our respective pharmaceutical research businesses
     
  • Focus on novel strategies for drug delivery, as well as clinical trail’s latest updates to drive your market share significantly;
     
  • Learn on the applications of innovative DDS for treating major diseases to advance the drug portfolio industrialization pathways;
     
  • Listen to the case-studies by the pioneers in the field of drug delivery technologies to differentiate your product competitiveness step by step;

Contact:Organizer

Tel:021-61573930,61573919

Fax:021-61577299

E-mail:askconference@ubm.com

Website:http://www.ndds-china.com

PharmaSources Customer Service